Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001558370-16-006510
Filing Date
2016-06-28
Accepted
2016-06-28 16:41:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 acrs-20160628424b4.htm 424B4 271171
2 acrs20160628xs1001.jpg GRAPHIC 5731
  Complete submission text file 0001558370-16-006510.txt   280164
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-212095 | Film No.: 161736561
SIC: 2834 Pharmaceutical Preparations